US Stock MarketDetailed Quotes
HQL abrdn Life Sciences Investors
- 14.970
- 0.0000.00%
Trading Nov 6 15:56 ET
392.39MMarket Cap149.70P/E (TTM)
0.000High0.000Low1.35KVolume14.930Open14.970Pre Close0.00Turnover0.01%Turnover RatioLossP/E (Static)26.21MShares15.68452wk High0.93P/B392.39MFloat Cap10.15452wk Low1.33Dividend TTM26.21MShs Float16.731Historical High8.88%Div YieldTTM0.00%Amplitude0.539Historical Low0.000Avg Price1Lot Size
abrdn Life Sciences Investors Key Stats
Quarterly+Annual
YOY
| (Q2)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q2)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | (Q2)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q2)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash cash equivalents and federal funds sold | ---- | 7.19%477 | 7.19%477 | -99.72%822 | -55.05%445 | -55.05%445 | 183,800.63%292.4K | --990 | --990 | -80.20%159 |
| -Cash and cash equivalents | ---- | 7.19%477 | 7.19%477 | -99.72%822 | -55.05%445 | -55.05%445 | 183,800.63%292.4K | --990 | --990 | -80.20%159 |
| Receivables | 759.17%110.13K | 709.12%5.04M | 709.12%5.04M | -99.59%12.82K | 333.95%623.47K | 333.95%623.47K | 57,197.26%3.1M | 94.42%143.67K | 94.42%143.67K | -99.88%5.41K |
| Prepaid assets | 50.60%49.99K | 3.63%26.09K | 3.63%26.09K | 3.87%33.19K | -4.27%25.18K | -4.27%25.18K | -27.06%31.95K | -2.43%26.3K | -2.43%26.3K | 26.76%43.81K |
| -Available for sale securities | 15.55%13.84M | ---- | ---- | --11.98M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other assets | 1,400.53%2.84K | 0.00%189 | 0.00%189 | -91.42%189 | -97.17%189 | -97.17%189 | -97.26%2.2K | -92.73%6.67K | -92.73%6.67K | -78.67%80.33K |
| Total assets | 2.14%441.95M | -2.92%402.6M | -2.92%402.6M | -3.51%432.69M | -22.36%414.73M | -22.36%414.73M | -10.91%448.41M | 10.33%534.19M | 10.33%534.19M | 25.18%503.33M |
| Liabilities | ||||||||||
| Payables | -92.87%665.12K | ---- | ---- | -22.36%9.33M | 86.11%16.19M | 86.11%16.19M | 27,169.06%12.02M | 62,297.12%8.7M | 62,297.12%8.7M | --44.08K |
| -Accounts payable | --229.3K | ---- | ---- | ---- | --5.1M | --5.1M | 7,935.07%3.54M | ---- | ---- | --44.08K |
| -Other payable | -95.33%435.82K | ---- | ---- | 10.07%9.33M | 27.49%11.09M | 27.49%11.09M | --8.48M | 62,297.12%8.7M | 62,297.12%8.7M | ---- |
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --209.84K | 11,002.51%1.34M | 11,002.51%1.34M | ---- |
| Total liabilities | -91.24%879.91K | -96.04%666.96K | -96.04%666.96K | -22.36%10.04M | 56.56%16.82M | 56.56%16.82M | 1,891.35%12.94M | 1,705.34%10.75M | 1,705.34%10.75M | 11.01%649.63K |
| Shareholders'equity | ||||||||||
| Share capital | 4.34%273.51K | 4.33%267.91K | 4.33%267.91K | 4.25%262.12K | 4.10%256.8K | 4.10%256.8K | 3.56%251.44K | 3.29%246.68K | 3.29%246.68K | -99.93%242.79K |
| -common stock | 4.34%273.51K | 4.33%267.91K | 4.33%267.91K | 4.25%262.12K | 4.10%256.8K | 4.10%256.8K | 3.56%251.44K | 3.29%246.68K | 3.29%246.68K | -99.93%242.79K |
| Paid-in capital | 3.81%410.6M | 3.88%403.15M | 3.88%403.15M | 3.85%395.55M | 4.19%388.1M | 4.19%388.1M | 4.57%380.89M | 4.54%372.49M | 4.54%372.49M | --364.25M |
| Retained earnings | 12.52%30.19M | -115.51%-1.48M | -115.51%-1.48M | -50.62%26.83M | -93.66%9.55M | -93.66%9.55M | -60.68%54.34M | 18.63%150.7M | 18.63%150.7M | 166.46%138.19M |
| Total stockholders'equity | 4.36%441.07M | 1.01%401.93M | 1.01%401.93M | -2.95%422.65M | -23.98%397.9M | -23.98%397.9M | -13.37%435.47M | 8.24%523.44M | 8.24%523.44M | 25.20%502.68M |
| Total equity | 4.36%441.07M | 1.01%401.93M | 1.01%401.93M | -2.95%422.65M | -23.98%397.9M | -23.98%397.9M | -13.37%435.47M | 8.24%523.44M | 8.24%523.44M | 25.20%502.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data